SCHEMBL17845528

SCHEMBL17845528

Cc1nnc(-n2c(=O)n(C)c3c(F)cc(S(N)(=O)=O)c(C4(C)CC4)c32)s1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PARG Q86W56 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28533960 0.71 PARG (0.51) PARG
SCHEMBL17845500 0.70 PARG (1.00) PARG
SCHEMBL31121992 0.67 PARG (1.00) PARG
SCHEMBL17845538 0.67 PARG (1.00) PARG
SCHEMBL17845231 0.64 PARG (0.68) PARG
SCHEMBL31122052 0.64 PARG (0.68) PARG
SCHEMBL28536670 0.62 PARG (0.54) PARG
SCHEMBL17845535 0.62 PARG (1.00) PARG
SCHEMBL31121996 0.62 PARG (0.49) PARG
SCHEMBL28531505 0.62 PARG (0.49) PARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3233845-A1 PARG INHIBITORY COMPOUNDS Cancer Research Technology Limited (GB) 2017-10-25 EP disclosed
WO-2016097749-A1 PARG INHIBITORY COMPOUNDS CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2016-06-23 WO disclosed